These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Intravenous immunoglobulins in children with new onset dilated cardiomyopathy. Heidendael JF; Den Boer SL; Wildenbeest JG; Dalinghaus M; Straver B; Pajkrt D Cardiol Young; 2018 Jan; 28(1):46-54. PubMed ID: 28797313 [TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin treatment for acute fulminant inflammatory cardiomyopathy: series of six patients and review of literature. Goland S; Czer LS; Siegel RJ; Tabak S; Jordan S; Luthringer D; Mirocha J; Coleman B; Kass RM; Trento A Can J Cardiol; 2008 Jul; 24(7):571-4. PubMed ID: 18612500 [TBL] [Abstract][Full Text] [Related]
7. Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy. McNamara DM; Rosenblum WD; Janosko KM; Trost MK; Villaneuva FS; Demetris AJ; Murali S; Feldman AM Circulation; 1997 Jun; 95(11):2476-8. PubMed ID: 9184576 [TBL] [Abstract][Full Text] [Related]
8. Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins. Maisch B; Hufnagel G; Kölsch S; Funck R; Richter A; Rupp H; Herzum M; Pankuweit S Herz; 2004 Sep; 29(6):624-36. PubMed ID: 15912438 [TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load. Dennert R; Velthuis S; Schalla S; Eurlings L; van Suylen RJ; van Paassen P; Tervaert JW; Wolffs P; Goossens VJ; Bruggeman C; Waltenberger J; Crijns HJ; Heymans S Antivir Ther; 2010; 15(2):193-201. PubMed ID: 20386074 [TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin in children with acute myocarditis and/or early dilated cardiomyopathy. Prasad AN; Chaudhary S Indian Pediatr; 2014 Jul; 51(7):583-4. PubMed ID: 25031145 [TBL] [Abstract][Full Text] [Related]
11. Ivabradine in Children With Dilated Cardiomyopathy and Symptomatic Chronic Heart Failure. Bonnet D; Berger F; Jokinen E; Kantor PF; Daubeney PEF J Am Coll Cardiol; 2017 Sep; 70(10):1262-1272. PubMed ID: 28859790 [TBL] [Abstract][Full Text] [Related]
12. Correlations of the changes in bioptic findings with echocardiographic, clinical and laboratory parameters in patients with inflammatory cardiomyopathy. Krejci J; Hude P; Poloczkova H; Zampachova V; Stepanova R; Freiberger T; Nemcova E; Spinarova L Heart Vessels; 2016 Mar; 31(3):416-26. PubMed ID: 25539624 [TBL] [Abstract][Full Text] [Related]
13. Myocarditis in children with dilated cardiomyopathy: incidence and outcome after dual therapy immunosuppression. Kleinert S; Weintraub RG; Wilkinson JL; Chow CW J Heart Lung Transplant; 1997 Dec; 16(12):1248-54. PubMed ID: 9436137 [TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of patients with virus-negative chronic myocarditis or inflammatory cardiomyopathy after immunosuppressive therapy. Escher F; Kühl U; Lassner D; Poller W; Westermann D; Pieske B; Tschöpe C; Schultheiss HP Clin Res Cardiol; 2016 Dec; 105(12):1011-1020. PubMed ID: 27312326 [TBL] [Abstract][Full Text] [Related]
16. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life. Abdel-Salam Z; Rayan M; Saleh A; Abdel-Barr MG; Hussain M; Nammas W Cardiol J; 2015; 22(2):227-32. PubMed ID: 25179314 [TBL] [Abstract][Full Text] [Related]